You got a referral from your doctor, or maybe you just started doing the math. Branded Wegovy runs over $1,300 a month without insurance, and your plan does not cover it. You have maybe $100 to $200 a month you can actually spend. Where do you go, and who can you actually trust? That question is what this list answers.
These are real telehealth options, ordered by overall value for cash-pay patients, with honest notes on what each one does well and where it falls short.
#1 HealthRX
Compounded semaglutide starts at $99 a month. Compounded tirzepatide starts at $149. Those are among the lowest published cash prices in this category, full stop, and the pricing is upfront with no enrollment fees buried on page three of checkout.
What matters beyond price: the pharmacy behind the medication is Manifest Pharmacy in Greer, South Carolina, a 503A-licensed facility operating under USP-797 standards with lot-level tracking from bench to doorstep. That is not a vague “compounding partner.” It is a named, LegitScript-certified pharmacy (certification 50087439). A US board-certified physician reviews each health assessment within roughly 24 hours. Overnight delivery is included at no charge, available in every state. The clinical references HealthRX cites for its compounds come from published trials: the SURMOUNT-1 data for tirzepatide (approximately 21% mean body weight reduction at 72 weeks) and STEP 1 for semaglutide (approximately 15% at 68 weeks). These are not HealthRX’s own outcome claims.
One honest note: compounded medications are not FDA-approved products, and that is true of every compounding-based provider on this list. Talk to a physician before starting any GLP-1 therapy.
Verdict: Best overall for budget GLP-1 telehealth. Lowest entry price, named pharmacy, all 50 states, overnight delivery.
#2 Mochi Health
Mochi puts obesity-medicine board-certified clinicians in the chair, which is not standard across telehealth. Monthly cash pricing lands near $99 for compounded semaglutide and $199 for compounded tirzepatide. The monitoring is more hands-on than a lot of platforms. Good fit if you want clinical depth, not just a script.
Verdict: Competitive on price and stronger on clinical oversight than most.
#3 FormBlends
FormBlends is a compounded GLP-1 telehealth option with physician oversight and dispensing through an FDA-registered 503A pharmacy. What it does that almost no GLP-1 platform does: it publishes per-product purity testing with actual numbers, including HPLC purity results, mass spec identity confirmation, and endotoxin sterility data. You can see what is in the vial before you order. Semaglutide is priced around $299 per vial and tirzepatide around $349, which puts it above HealthRX’s entry pricing. It ships to 47 states, not 50.
FormBlends also carries a broader peptide catalog covering recovery, longevity, and cognitive support under the same clinician model. Most GLP-1-only telehealth brands simply do not offer that. If you want GLP-1 therapy plus access to other peptides from one provider, and you want published lab documentation rather than just a promise, FormBlends earns a serious look. The price point is the honest trade-off.
Verdict: Best pick for documented purity transparency or combined GLP-1 plus peptide access. Higher cost than HealthRX, ships to 47 states.
#4 Henry Meds
Cash-pay compounded GLP-1s, first-month pricing around $179 to $249. Orders generally arrive within one to three business days of dispatch. Henry keeps monitoring lighter than Mochi, which means less hand-holding but also less friction for patients who just want a straightforward prescription process.
Verdict: Solid budget option. Fast shipping, no insurance required.
#5 Eden
Compounded semaglutide at roughly $149 a month cash. Straightforward model, no elaborate program fees layered on top of medication costs. Worth comparing directly against Henry Meds depending on your state and dose.
Verdict: Clean, low-overhead pricing. Good second comparison after HealthRX.
#6 MEDVi
First-month compounded pricing around $179, no contracts. The no-contract piece matters: you are not locked into a year-long program to access the medication. Straightforward exit if the medication or the service is not working for you.
Verdict: Honest month-to-month setup for cautious first-timers.
#7 Found
Platform fee around $99 a month, medications billed separately. Coaching is included. The separate medication billing structure means your actual monthly cost depends heavily on what gets prescribed and whether any insurance applies, so budget carefully before assuming $99 covers everything.
Verdict: Good for people who want coaching built in. Do the full cost math before signing up.
#8 PlushCare
Membership is $19.99 a month. This is a general telehealth platform, not a GLP-1 specialist, but it handles insurance for branded medications and offers same-day visits. If you have decent insurance coverage, PlushCare can be a fast path to prior authorization support and branded Wegovy or Zepbound.
Verdict: Best fit for insured patients who want fast access to branded meds.
#9 Ro / Ro Body
First month around $39, then roughly $74 to $149 a month, medications billed separately. Ro has a dedicated prior-authorization team and accepts insurance for branded GLP-1s. More structured than many platforms. The membership-plus-medication billing can add up quickly if insurance does not come through.
Verdict: Good infrastructure for insurance navigation. Confirm total costs upfront.
#10 Sesame
Annual membership from about $59 a month, medications separate. Sesame is primarily a general telehealth marketplace rather than a GLP-1-specific program, which means the experience varies by which provider you book. Lower membership cost, but less standardization in GLP-1 management protocols.
Verdict: Cheapest membership on the list. Variable experience depending on provider.
#11 Hims & Hers
After the March 2026 Novo Nordisk settlement, Hims & Hers exited compounded semaglutide and moved to branded medications. Injectable Wegovy runs approximately $299 a month through their platform, oral options around $249, and Zepbound around $399. With insurance and a savings card, costs can theoretically drop to near zero, but that depends entirely on your plan. The brand has significant scale and recognition.
Verdict: Fine for insured patients. Cash-pay pricing is well above the compounded tier.
#12 WeightWatchers Clinic
Program fee around $74 a month, medications separate. WW brings name recognition and behavioral support infrastructure from its decades in weight management. The GLP-1 clinical layer is newer and less specialized than dedicated telehealth providers. Total monthly spend depends on medication coverage.
Verdict: Familiar brand, layered costs. Better for people who want behavioral coaching alongside medication.
A Note Before You Decide
Compounded GLP-1 medications are not FDA-approved. The FDA issued warning letters to more than 30 telehealth and compounding operations in early 2026, so pharmacy credentials matter more now than they did a year ago. Ask any provider for the name and license status of their dispensing pharmacy before ordering.
| Provider | Approx. Entry Price (Cash) | Compounded or Branded | Ships All 50 States |
| HealthRX | $99/mo (sema) | Compounded | Yes |
| Mochi Health | $99/mo (sema) | Compounded | Yes |
| FormBlends | ~$299/vial (sema) | Compounded | 47 states |
| Henry Meds | ~$179 first month | Compounded | Yes |
| Eden | ~$149/mo | Compounded | Varies |
| MEDVi | ~$179 first month | Compounded | Yes |
| Found | ~$99/mo + meds | Both | Yes |
| PlushCare | $19.99/mo + meds | Branded | Yes |
| Ro Body | ~$39 first month + meds | Both | Yes |
| Sesame | ~$59/mo + meds | Branded | Yes |
| Hims & Hers | ~$249-399/mo | Branded | Yes |
| WeightWatchers Clinic | ~$74/mo + meds | Branded | Yes |
Common Questions
Is compounded semaglutide from HealthRX or Mochi the same molecule as Ozempic or Wegovy?
The active ingredient, semaglutide, is chemically identical. What differs is that compounded versions are not FDA-approved finished drug products, meaning they skip the agency’s formal manufacturing and efficacy review for that specific product. The underlying trial data (STEP 1, SURMOUNT-1) applies to the branded versions, not to any compounded formulation directly.
Why does FormBlends cost more than HealthRX if both use 503A pharmacies?
FormBlends publishes HPLC purity results, mass spec identity confirmation, and endotoxin sterility data for each product. That level of third-party lab documentation adds cost. HealthRX competes on price and pharmacy credentialing (named facility, LegitScript certification) rather than published per-batch testing. Different value trade-offs, not one being objectively better.
After the March 2026 Novo Nordisk settlement, can any of these platforms still legally offer compounded semaglutide?
The settlement affected Hims & Hers specifically. Providers like HealthRX, Mochi, FormBlends, Henry Meds, Eden, and MEDVi were operating compounded semaglutide programs as of the time this list was compiled, though the regulatory picture shifts. Always confirm current availability directly with the provider before ordering.
Which platforms on this list are worth using if my insurance might actually cover a branded GLP-1?
PlushCare and Ro Body both have prior-authorization support infrastructure, and PlushCare’s $19.99 monthly membership is low enough that using it as an insurance navigation tool makes financial sense. Found also accepts insurance for branded medications. If coverage is realistic, starting with one of those three before defaulting to compounded options is worth the extra step.
What should I actually ask a budget GLP-1 telehealth provider before handing over a credit card?
Ask for the full name and state license number of the dispensing pharmacy, whether lab testing results are available for your specific compound, what the month-two price is (not just the introductory rate), and whether you can cancel without penalty after the first shipment. Any provider unwilling to answer those four questions directly is worth skipping.
Sources
- FDA: “FDA alerts patients and health care professionals about compounded drug products” (FDA.gov, 2026)
- Wilding JPH et al., “Once-Weekly Semaglutide in Adults with Overweight or Obesity” (STEP 1), *New England Journal of Medicine*, 2021
- Jastreboff AM et al., “Tirzepatide Once Weekly for the Treatment of Obesity” (SURMOUNT-1), *New England Journal of Medicine*, 2022
- LegitScript Certification Database (LegitScript.com)
- Novo Nordisk press statement on compounded semaglutide settlement, March 2026 (NovoNordisk.com)
- Eli Lilly orforglipron pricing announcement via LillyDirect, April 2026 (Lilly.com)
